Breast Cancer Treatment Begins Clinical Trials in Taiwan

Breast Cancer Treatment Begins Clinical Trials in Taiwan:



'via Blog this'

Scans on Friday

I have a full day of scans, blood tests, you name it, at MD Anderson on Friday 2/21.  I'll be leaving after work (after 3pm on Thursday 2/19) and coming back on Saturday 2/22. Jesse has to work Friday, Saturday and Sunday and can't go.  I can go by myself, but if anyone wants to go along, it would be nice to have someone there.

Results of OPT-822/821 (822-001) Phase 1 Trial

Here is some information I found on the phase 1 trial of the clinical trial I am considering.  Mine will be the phase 2 of this same trial:

MSKCC completed Phase 1 safety studies of OPT-822/821 in prostate cancer patients and breast cancer patients in 1999 and
2001, respectively. In these studies, OPT-822/821 appeared to be well tolerated and to stimulate responses to tumor antigens.
Twenty-one of 27 metastatic breast cancer patients treated with OPT-822/821 in the study survived after four years, with 48% of
patients surviving more than nine years following completion of the Phase 1 safety study.

Info on the Vaccine Trial

Info on the trial they are asking me to participate in is located here:

http://utm-ext01a.mdacc.tmc.edu/dept/prot/clinicaltrialswp.nsf/Index/2012-0408

Vaccine trial

For those of you waiting to see which trial...here's the front page.  Will post more later...but this us a sneak peek for those who are more mbc savvy.

Today's Lesson

Sometimes you just have to sit back, let things go, see what happens, and hope for the best.

You always have a choice and the choice can be power

MD Anderson’s Dr. James Allison Wins 2014 Szent-Györgyi Prize; Yet Another Award for Cancer Immunotherapy

Immunotherapy is the concept behind the vaccine trial I am going down to MD Anderson for this week. Reading the article below, about yet another award going to a researcher at MD Anderson, gives me great hope and confidence that I am going down for the right therapy at the right place.  Perhaps this will be the trial that I am going down to try.  It's already showing benefits in metastatic melanoma, and they are now testing it on other types of cancer. Always hope that there is a possibility for metastatic breast cancer cure in our lifetime.

 

Feb 10, 2014 10:24 am | Mike Nace
MD Anderson cancer immunotherapy pioneer Dr. James Allison has been awarded with yet another research award for his recent cancer therapy research, this time from The National Foundation for Cancer Research (NFCR). The Foundation announced last week that Dr. Allison, Chairman of the Department of Immunology at The University of Texas MD Anderson Cancer Center, has ...

Read Article

18 things mentally strong people do

Repeat after me